184 related articles for article (PubMed ID: 10964480)
1. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
Duan W; Guo Z; Mattson MP
Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
[TBL] [Abstract][Full Text] [Related]
2. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.
Yang L; Sugama S; Mischak RP; Kiaei M; Bizat N; Brouillet E; Joh TH; Beal MF
Neurobiol Dis; 2004 Nov; 17(2):250-9. PubMed ID: 15474362
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the involvement of Par-4 in ischemic neuron cell death.
Culmsee C; Zhu Y; Krieglstein J; Mattson MP
J Cereb Blood Flow Metab; 2001 Apr; 21(4):334-43. PubMed ID: 11323519
[TBL] [Abstract][Full Text] [Related]
4. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
[TBL] [Abstract][Full Text] [Related]
5. Systemic administration of 3-nitropropionic acid points out a different role for active caspase-3 in neurons and astrocytes.
Duran-Vilaregut J; Del Valle J; Manich G; Junyent F; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Neurochem Int; 2010 Feb; 56(3):443-50. PubMed ID: 19969037
[TBL] [Abstract][Full Text] [Related]
6. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease.
Duan W; Zhang Z; Gash DM; Mattson MP
Ann Neurol; 1999 Oct; 46(4):587-97. PubMed ID: 10514095
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
8. Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice.
Alexi T; Hughes PE; Knüsel B; Tobin AJ
Exp Neurol; 1998 Sep; 153(1):74-93. PubMed ID: 9743569
[TBL] [Abstract][Full Text] [Related]
9. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
[TBL] [Abstract][Full Text] [Related]
10. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid.
Dautry C; Vaufrey F; Brouillet E; Bizat N; Henry PG; Condé F; Bloch G; Hantraye P
J Cereb Blood Flow Metab; 2000 May; 20(5):789-99. PubMed ID: 10826529
[TBL] [Abstract][Full Text] [Related]
11. Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid.
Blum D; Hemming FJ; Galas MC; Torch S; Cuvelier L; Schiffmann SN; Sadoul R
Neurosci Lett; 2004 Sep; 368(3):309-13. PubMed ID: 15364417
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF.
Puerta E; Hervias I; Barros-Miñones L; Jordan J; Ricobaraza A; Cuadrado-Tejedor M; García-Osta A; Aguirre N
Neurobiol Dis; 2010 May; 38(2):237-45. PubMed ID: 20109548
[TBL] [Abstract][Full Text] [Related]
13. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
[TBL] [Abstract][Full Text] [Related]
14. Caspase-dependent and -independent cell death induced by 3-nitropropionic acid in rat cortical neurons.
Almeida S; Brett AC; Góis IN; Oliveira CR; Rego AC
J Cell Biochem; 2006 May; 98(1):93-101. PubMed ID: 16365893
[TBL] [Abstract][Full Text] [Related]
15. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.
Maragos WF; Jakel RJ; Pang Z; Geddes JW
Exp Neurol; 1998 Dec; 154(2):637-44. PubMed ID: 9878198
[TBL] [Abstract][Full Text] [Related]
16. Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.
Palfi S; Riche D; Brouillet E; Guyot MC; Mary V; Wahl F; Peschanski M; Stutzmann JM; Hantraye P
Exp Neurol; 1997 Jul; 146(1):135-41. PubMed ID: 9225746
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats.
Kim JH; Kim S; Yoon IS; Lee JH; Jang BJ; Jeong SM; Lee JH; Lee BH; Han JS; Oh S; Kim HC; Park TK; Rhim H; Nah SY
Neuropharmacology; 2005 Apr; 48(5):743-56. PubMed ID: 15814108
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain.
Bizat N; Galas MC; Jacquard C; Boyer F; Hermel JM; Schiffmann SN; Hantraye P; Blum D; Brouillet E
Neuropharmacology; 2005 Oct; 49(5):695-702. PubMed ID: 15998526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
